Navigation Links
Influenza drug delayed

The maker of the only medication approved to treat both major strains of influenza in young children said the drug was not available for the start of this flu season because production problems delayed its distribution. The medication, Tamiflu Oral Suspension product, was supposed to be launched this season. Hoffmann-La Roche informed the FDA of its production problems, but FDA spokeswoman Sharon Jayne said the company was not required to do so. //

Tamiflu is one of two FDA approved drugs in a new class of medications, which attack the virus that causes the flu and stops it from spreading. The other medication, Relenza, is equally effective but can cause more side effects and is more difficult to use since it is inhaled twice a day. Both medications must be used within two days of developing symptoms to be effective.

Tamiflu pills for adults and older children were approved by the U.S. Food and Drug Administration in October 1999 and are available. The liquid formula for children 1 or older was approved in December 2000, but was not available until January 2001. Flu season usually occurs between December and April.

Tamiflu can shorten the duration of the flu by one to two days and reduce major complications such as ear infections and bronchitis. Ear infections, the most common complication in children, can be reduced by 44 percent. Tamiflu can reduce the spread of flu in families. When the first person in a household who developed the flu took the drug as well as all other family members, 63 percent of the households were protected against the flu. The results with this drug are marvelous. Two other flu medications, amantadine and rimantadine, are available but only treat Influenza A.
'"/>




Page: 1

Related medicine news :

1. Chances are high for Avian Influenza virus altering its form
2. Influenza Avian Flu strain has become more contagious and dangerous.
3. A Vaccine for the impending pandemic Avian Influenza
4. Influenza Vaccination for children with neurological or neuromuscular disease
5. Avian Influenza: Government to set up expert committee
6. Resistant Influenza strains creates panic in US
7. Influenza Vaccination For The Elderly
8. Fao Declares Humans Spread Avian Influenza Virus
9. Statins Could Play Important Role In Influenza Pandemic
10. Zoo Animal Succumbs to Avian Influenza in Germany
11. India Says It Is ‘‘Avian Influenza Free Country
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... educational seminar to focus on current legislative activity and the latest regulatory concerns ... 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, at ...
(Date:5/26/2017)... ... 2017 , ... Boar’s Head Brand®, one of the nation’s ... entertaining that are sure to satisfy your guests’ flavor cravings, while adding delicious ... featured in these refreshingly balanced recipes are packed with flavor, creating the perfect ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Yisrayl Hawkins, ... new publication this week that is focusing on the Peace Agreements being discussed by ... Middle East sprint in a race to try to speed up peace talks in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: